Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Veterinary Science|June 25, 2019
Genetic and Phenotypic Characterization of the Etiological Agent of Canine Orchiepididymitis Smooth Brucella sp. BCCN84.3Caterina Guzmán-Verri, Marcela Suárez-Esquivel, Nazareth Ruíz-Villalobos, et al.
Plos One|August 10, 2017
Brucellosis in mammals of Costa Rica: An epidemiological surveyGabriela Hernández-Mora, Roberto Bonilla-Montoya, Osvaldo Barrantes-Granados, et al.
Nature Communications|January 10, 2013
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activationIsabel Romero-Camarero, Xiaoyu Jiang, Yasodha Natkunam, et al.
Psychophysiology|November 15, 2023
The psychophysiology of Mastermind: Characterizing response times and blinking in a high-stakes television game showSkyler Wyly, Neryanne Jinon, Timothy Francis, et al.
American Journal of Medical Genetics. Part A|November 27, 2019
International meeting on Wolf-Hirschhorn syndrome: Update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delayJulián Nevado, Karen S Ho, Marcella Zollino, et al.
Nature Communications|June 3, 2014
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphomaMichael R Green, Carolina Vicente-Dueñas, Isabel Romero-Camarero, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in miceCarolina Vicente-Dueñas, Lorena Fontán, Ines Gonzalez-Herrero, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 23, 2021
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthmaAntonio Nieto García, Teresa Garriga-Baraut, Ana María Plaza Martín, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 27, 2023
Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in SpainMaría Nieto-Cid, Teresa Garriga-Baraut, Ana Mª Plaza-Martín, et al.
Pageof 6